China Animal Husbandry Industry Co., Ltd. (SHSE: 600195)
Health Care · Pharmaceuticals · CN
CN¥6.71
+1.98% today · -12.7% 1Y
China Animal Husbandry Industry Co., Ltd. (SHSE: 600195) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.02B and employs 3,996 people.
Over the last twelve months the share price has lost 12.7%, trading between 5.76 and 9.03.
Tweenvest scores China Animal Husbandry Industry Co., Ltd. across four factors: quality 73/100, value 53/100, growth 30/100, dividend 49/100. Its strongest factor is quality.
600195 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.02B
- Revenue (TTM)
- $935.79M
- P/E
- 52.09
- EPS
- 0.13
- Dividend yield
- 0.76%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥9.03
- 52-week low
- CN¥5.76
- Avg volume (3M)
- —
- Shares outstanding
- 1.02B
- Employees
- 3,996
- Next earnings
- —
About China Animal Husbandry Industry Co., Ltd.
China Animal Husbandry Industry Co., Ltd. operates within China, specializing in the development, manufacturing, and sale of products designed for animal health and nutrition. Its comprehensive range includes veterinary pharmaceuticals, vaccines, and other biological remedies for animals, as well as various feed products and nutritional additives. The company also engages in the trading of raw materials. Established in 1998, its corporate headquarters are situated in Beijing, China.
- ISIN
- CNE000000Y03
- Founded
- 1998
- Listed since
- Jan 7, 1999
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.